Opioid-Induced Tolerance and Hyperalgesia

被引:0
作者
Sebastiano Mercadante
Edoardo Arcuri
Angela Santoni
机构
[1] Main Regional Center of Supportive/Palliative Care,Palliative/Supportive Care and Rehabilitation
[2] La Maddalena Cancer Center,undefined
[3] MD Anderson,undefined
[4] Regina Elena Cancer Institute,undefined
[5] University of Rome,undefined
来源
CNS Drugs | 2019年 / 33卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Opioids are very potent and efficacious drugs, traditionally used for both acute and chronic pain conditions. However, the use of opioids is frequently associated with the occurrence of adverse effects or clinical problems. Other than adverse effects and dependence, the development of tolerance is a significant problem, as it requires increased opioid drug doses to achieve the same effect. Mechanisms of opioid tolerance include drug-induced adaptations or allostatic changes at the cellular, circuitry, and system levels. Dose escalation in long-term opioid therapy might cause opioid-induced hyperalgesia (OIH), which is a state of hypersensitivity to painful stimuli associated with opioid therapy, resulting in exacerbation of pain sensation rather than relief of pain. Various strategies may provide extra-opioid analgesia. There are drugs that may produce independent analgesic effects. A tailored treatment provided by skilled personnel, in accordance with the individual condition, is mandatory. Any treatment aimed at reducing opioid consumption may be indicated in these circumstances. Interventional techniques able to decrease the pain input may allow a decrease in the opioid dose, thus reverting the mechanisms producing tolerance of OIH. Intrathecal therapy with local anesthetics and a sympathetic block are the most common techniques utilized in these circumstances.
引用
收藏
页码:943 / 955
页数:12
相关论文
共 405 条
[31]  
Wood E(2005)Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance J Neurosci. 25 409-238
[32]  
Montaner J(2015)Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat Handb Exp Pharmacol. 227 207-578
[33]  
Gupta S(2013)Cholecystokinin in the rostral ventromedial medulla mediates opioid- induced hyperalgesia and antinociceptive tolerance Life Sci. 93 573-15963
[34]  
Silverman SM(2013)The relationship between opioids and immune signaling in the spinal cord J Neurosci. 33 15952-280
[35]  
Compton P(2001)The involvement of midbrain astrocyte in the development of morphine tolerance J Endotoxin Res 7 277-238
[36]  
Canamar CP(2015)Blockade of toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine Handb Exp Pharmacol. 227 207-407
[37]  
Hillhouse M(2004)Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies Neurochem Int 45 397-5861
[38]  
Ling W(2005)The relationship between opioids and immune signaling in the spinal cord Proc Natl Acad Sci USA 102 5856-583
[39]  
Rieb LM(2010)Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain Neuroscience 165 569-473
[40]  
Norman WV(2004)The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy Eur J Neurosci 20 467-6330